Physician profile
Ryan N Bennett
NPI 1679782221
$716.96
in general payments reported to CMS, 2019-2025
19 companies · $14.96 in 2025
The $14.96 reported for 2025 was less than what a typical Family Medicine provider received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $626 · 2020: $75.98 · 2025: $14.96.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $14.96.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $14.96 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Lilly USA, LLC | $195.81 | 2019-2020 | |
| Novo Nordisk INC | $182.44 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $37.79 | 2019 | |
| Pfizer INC. | $35.05 | 2019 | |
| Sunovion Pharmaceuticals INC. | $34.58 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $34.10 | 2019-2020 | |
| Amgen INC. | $24.32 | 2019 | |
| Amarin Pharma, INC. | $21.62 | 2019 | |
| Mallinckrodt Enterprises LLC | $19.47 | 2019 | |
| Shire North American Group INC | $17.44 | 2019 | |
| Genentech USA, INC. | $16.53 | 2019 | |
| Boston Scientific Corporation | $14.96 | 2025 | Avvigo Guidance System |
| Supernus Pharmaceuticals, INC. | $14.57 | 2019 | |
| Glaxosmithkline, LLC. | $11.86 | 2019 | |
| Ironshore Pharmaceuticals INC. | $11.84 | 2019 |
Show all 19 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Zyla Life Sciences, INC. | $11.82 | 2019 | |
| Astellas Pharma US INC | $10.98 | 2019 | |
| Janssen Pharmaceuticals, INC | $10.91 | 2019 | |
| Astrazeneca Pharmaceuticals Lp | $10.87 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Bennett listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.